Hypertension treatment in a medicare population: Adherence and systolic blood pressure control*
References (39)
- et al.
Resistant hypertension revisited: A comparison of two university-based cohorts
Am J Hypertens
(2005) - et al.
The effects of initial drug choice and comorbidity on antihypertensive therapy compliance: Results from a population-based study in the elderly
Am J Hypertens
(1997) - et al.
Appropriate reductions in compliance among well-controlled hyper tensive patients
J Clin Epidemiol
(1991) - et al.
Medication adherence before an increase in anti hypertensive therapy: A cohort study using pharmacy claims data
Clin Ther
(2005) - et al.
Refill persistence with chronic medication assessed from a pharmacy database was influenced by method of calculation
J Clin Epidemiol
(2006) - et al.
Relationship between daily dose frequency and adherence to anti hypertensive pharmacotherapy: Evidence from a meta-analysis
Clin Ther
(2002) - et al.
Toward a standard definition and measurement of persistence with drug therapy: Examples from research on statin and antihypertensive utilization
Clin Ther
(2006) - et al.
The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: The JNC 7 report
JAMA
(2003) - et al.
Trends in prevalence, awareness, treatment, and control of hypertension in the United States, 1988–2000
JAMA
(2003) Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. Final results of the Systolic Hypertension in the Elderly Program (SHEP)
JAMA
(1991)
Effects ofACE inhibitors, calcium antagonists, and other blood-pressure-lowering drugs: Results of prospectively designed overviews of randomised trials
Lancet
Clinical practice. Resistant or difficult-to-control hypertension
N Engl J Med
How can we improve adherence to blood pressure-lowering medication in ambulatory care? Systematic review of randomized controlled trials
Arch Intern Med
Relationship of blood pressure control to adherence with anti hypertensive monotherapy in 13 managed care organizations
J Manag Care Pharm
The Anti hypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial. Major outcomes in high-risk hypertensive patients randomized to angiotensinconverting enzyme inhibitor or calcium channel blocker vs diuretic: The Anti hypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)
JAMA
Validation of patient reports, automated pharmacy records, and pill counts with electronic monitoring of adherence to anti hypertensive therapy
Med Care
Predictors of adherence with anti hypertensive and lipid-lowering therapy
Arch Intern Med
Clinical outcomes and adherence to medications measured by claims data in patients with diabetes
Diabetes Care
Cited by (114)
Blood Pressure Control in a Diverse Population of Hypertensive Patients With Heart Failure
2023, American Journal of CardiologyInitial Combination Therapies
2023, Hypertension: A Companion to Braunwald's Heart DiseaseA systematic review of measures estimates adherence and persistence to multiple medications
2019, Journal of Clinical EpidemiologyCitation Excerpt :For example, Ferrario et al. [21], used a period of at least 60 days before discontinuation of index therapy to define a medication addition for a blood pressure-lowering medication in a class other than the index drug, whereas An and Nichol [17] defined addition as medications prescribed to treat the comorbid conditions other than the index condition during the 6-month period (index diabetes with comorbid hypertension or vice versa). Third, measuring adherence to “any medication”: Twelve studies assessed adherence from number of days with at least one medication available and defined patients as being adherent when they had collected at least 80% of one, that is, “any medication” [6,7,14,15,18,22–24,28,33,35,38]. Also the studies using this measure first assessed adherence for medication at class level and then calculated adherence to multiple medication classes at therapeutic level for glucose-lowering [6,7,14,18,33,38], blood pressure-lowering [15,18,22–24,28,35], or lipid-lowering medication [18,28].
Single-Pill Combinations in the Treatment of Hypertension in Adults: Beyond Convenience
2018, Canadian Journal of DiabetesCitation Excerpt :Most patients who are hypertensive require at least 2 medications to achieve blood pressure (BP) targets, as demonstrated by large hypertension trials (4–10). Furthermore, adherence to treatment decreases significantly with the increasing number of pills patients require (11,12). This questions the traditional model of uptitration from monotherapy (13) and has spun interest in single-pill combinations.
Use of Combination Therapies
2018, Hypertension: A Companion to Braunwald's Heart Disease
- *
The results from this study were presented in abstract form at the 11th Annual HMO Research Network Conference, April 4–6, 2005, Santa Fe, New Mexico, and at the Academy Health 2005 Annual Research Meeting, June 26–28, 2005, Boston, Massachusetts.